However, considering that digoxin can target Na+/K+ ATPase (Ren et al., 2021) and regulate other pathways (Lin et al., 2015; Wang et al., 2017), further studies are needed to determine whether any of the effects of digoxin in the cancer cells is through RORγ or other pathways. Here, RORC is linked to cancer.